BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma
BCMA CAR-T therapy was safe and effective as a salvage treatment for PBM, and its toxicity was controllable. Future research will examine the use of CAR-T therapy as part of combination regimens.
Authors
- Ying Jiang (ORCID: https://orcid.org/0000-0003-2848-9840)
- Liqing Kang (ORCID: https://orcid.org/0000-0002-9840-9060)
- Su Li (ORCID: https://orcid.org/0009-0006-5772-2743)
- Jun Zhu (ORCID: https://orcid.org/0000-0001-9666-8010)
- Jing Deng
- Chengwei Jin
Institutions
- Beijing Tongren Hospital (CN)
- Shanghai Traditional Chinese Medicine Hospital (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-03-27
- DOI
- https://doi.org/10.1080/16078454.2025.2481555
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00